IRIS
Zambelli, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.452
NA - Nord America 3.248
EU - Europa 1.014
SA - Sud America 943
AF - Africa 205
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.105
SG - Singapore 1.891
BR - Brasile 735
CN - Cina 718
VN - Vietnam 409
FI - Finlandia 189
NG - Nigeria 145
IE - Irlanda 134
DE - Germania 124
IT - Italia 118
HK - Hong Kong 100
GB - Regno Unito 99
FR - Francia 96
AR - Argentina 88
IN - India 71
CA - Canada 53
NL - Olanda 48
MX - Messico 46
ID - Indonesia 44
RU - Federazione Russa 40
EC - Ecuador 36
IQ - Iraq 30
BD - Bangladesh 29
SE - Svezia 28
PL - Polonia 23
CL - Cile 21
ES - Italia 20
JP - Giappone 20
ZA - Sudafrica 20
AU - Australia 19
UA - Ucraina 19
CO - Colombia 18
PK - Pakistan 17
PY - Paraguay 17
MA - Marocco 14
UZ - Uzbekistan 12
VE - Venezuela 12
TR - Turchia 11
KZ - Kazakistan 10
CZ - Repubblica Ceca 9
IL - Israele 9
LT - Lituania 8
SA - Arabia Saudita 8
CR - Costa Rica 7
EG - Egitto 7
JM - Giamaica 7
MY - Malesia 7
NO - Norvegia 7
PA - Panama 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
DO - Repubblica Dominicana 6
KE - Kenya 6
OM - Oman 6
RO - Romania 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
GT - Guatemala 5
JO - Giordania 5
PE - Perù 5
PH - Filippine 5
TH - Thailandia 5
AZ - Azerbaigian 4
CH - Svizzera 4
HN - Honduras 4
NP - Nepal 4
PT - Portogallo 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
IR - Iran 3
KG - Kirghizistan 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KR - Corea 2
MD - Moldavia 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
AO - Angola 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
EU - Europa 1
GY - Guiana 1
HU - Ungheria 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 8.877
Salva come PNG Salva come JPEG
Città #
Singapore 785
Ashburn 393
The Dalles 313
San Jose 260
Shanghai 241
Chandler 218
New York 217
Helsinki 189
Beijing 180
Ho Chi Minh City 160
Benin City 143
Dublin 133
Dallas 123
Princeton 114
Lawrence 113
Los Angeles 93
Hong Kong 90
Hanoi 88
Wilmington 77
Boardman 63
São Paulo 61
Santa Clara 60
Paris 59
London 43
Amsterdam 36
Rio de Janeiro 29
San Mateo 29
Buffalo 28
Phoenix 25
Milan 19
Warsaw 19
Brasília 18
Mexico City 18
Montreal 18
Ann Arbor 16
Belo Horizonte 16
Seattle 16
Brooklyn 15
Da Nang 15
Fairfield 15
Haiphong 15
Chennai 14
Guayaquil 13
Leawood 13
Mumbai 13
Johannesburg 12
Quito 12
Salvador 12
Tokyo 12
Boston 11
Fortaleza 11
Tashkent 11
Thái Bình 11
Buenos Aires 10
Falkenstein 10
Frankfurt am Main 10
Porto Alegre 10
Toronto 10
Asunción 9
Baghdad 9
Charlotte 9
Chicago 9
Curitiba 9
Florence 9
Munich 9
Orem 9
Poplar 9
San Francisco 9
Assago 8
Biên Hòa 8
Denver 8
Naples 8
Thái Nguyên 8
Woodbridge 8
Cincinnati 7
Hangzhou 7
Hải Dương 7
Kyiv 7
Moscow 7
Pasadena 7
Pune 7
Reston 7
Ribeirão Preto 7
Santo André 7
Stockholm 7
Belém 6
Brno 6
Brussels 6
Cairo 6
Council Bluffs 6
Erbil 6
Evanston 6
Guarulhos 6
Manchester 6
Norwalk 6
Recife 6
Atlanta 5
Bắc Ninh 5
Cape Town 5
Dhaka 5
Totale 5.059
Salva come PNG Salva come JPEG
Nome #
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants 133
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 115
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signature 114
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study 97
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 93
ACUTE UPPER GASTROINTESTINAL BLEEDING (AUGB) IN ITALY: AN INTERIM ANALYSIS OF THE ORGANIZATIONAL ASPECTS CARING AN EVOLVING DISEASE 89
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 87
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen - A pilot study in patients with refractory malignancies 87
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 84
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. 81
Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19 81
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? 80
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 80
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial 79
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer 78
Cellular and molecular determinants of all‐ trans retinoic acid sensitivity in breast cancer: Luminal phenotype and α expression 76
Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling 76
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients 75
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis 74
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform 74
Clinical Review on the Management of Breast Cancer Visceral Crisis 72
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 72
TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTRO INTESTINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY 72
Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer 71
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe 69
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy 69
PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY 67
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score 67
A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression 67
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 66
Bone-Active Drugs in Pre-Menopausal Women with Breast Cancer Under Hormone Deprivation Therapies 65
Prospective multicenter quality assessment of endotherapy of biliary stones: does center volume matter? 65
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 64
An ICT infrastructure to integrate clinical and molecular data in oncology research 64
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective. 63
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971 63
Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients 63
trattamento conservativo dell' osteonecrosi spontaea del ginocchio in fase iniziale con campi pulsati: studio a 2 anni di follow-up minimo 62
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective 62
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 61
Opportunities and Challenges of Synthetic Data Generation in Oncology 61
OUTPATIENT MANAGEMENT OF PATIENTS WITH GLASGOW-BLATCHFORD BLEEDING SCORE LOW-RISK UPPER-GASTROINTESTINAL HEMORRHAGE: A MULTICENTER VALIDATION STUDY IN ITALY 61
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies 61
Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatment 61
Clinical toxicity of cryopreserved circulating progenitor cells infusion 61
Absence of the K303R estrogen receptor alpha mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment 61
Circulating CD33+large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+monocytes with their CD16+subset 61
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 61
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY 61
A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer 60
Cellular and molecular determinants of breast cancer sensitivity to all-trans retinoic acid: Identification of a gene expression fingerprint predicting responsiveness 60
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC) 59
Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy 58
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 58
No correlation between plasma D-dimer levels and lymph node involvement in operable breast cancer 58
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 57
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) 57
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 57
MORTALITY IN UPPER GASTROINTESTINAL BLEEDING IN ITALY: DATA FROM NATIONAL SURVEY 57
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry 57
Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: A new sensitive one step method without false positive results 57
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8(+) subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence 57
Trabectedin for the treatment of breast cancer 57
Remodelling of the Ca2+ signalling machinery in endothelial progenitor cells isolated from breast cancer patients 57
ONCO-i2b2: Improve Patients Selection through Case-Based Information Retrieval TechniquesData Integration in the Life Sciences 57
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 56
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 55
Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer 55
Pulmonary function and complications following chemotherapy and stem cell support in breast cancer 55
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128 55
STEM-CELL FACTOR AND INTERLEUKIN-6, ALONE OR IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, DO NOT AFFECT THE GROWTH OF SOLID TUMOR-CELL LINES 54
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 54
Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation 54
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 54
Targeting triple negative breast cancer: Is p53 the answer? 54
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 53
Short commentaries on data published by Petit et al. on locoregional risk after lipofilling in breast cancer patients 53
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 53
Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma 52
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 52
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy 52
An epirubicin/paclitaxel combination mobilizes large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen 52
COVID-19 Sequelae and the Host Pro-Inflammatory Response: An Analysis From the OnCovid Registry 51
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast 51
Retinoids and breast cancer: from basic studies to the clinic and back again 51
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma 51
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 50
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer 50
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction 50
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study 50
Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study 50
Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study 50
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 50
Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives 49
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer 49
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2 49
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 49
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 49
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy 49
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors 49
Totale 6.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.279
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022474 4 1 4 17 5 6 7 12 183 80 136 19
2022/20231.057 248 48 135 86 98 62 5 53 100 140 67 15
2023/20241.012 71 80 157 47 36 197 54 46 27 31 100 166
2024/20251.583 43 7 12 20 23 273 104 85 218 418 172 208
2025/20264.838 655 290 374 740 243 154 1.011 242 327 366 272 164
Totale 9.100